Search results for: “diet “


  • Panelists review ADA criteria for defining ‘remission’ in type 2 diabetes

    Last year, an international group of experts convened by the ADA published a consensus report on the clinical definition of “remission” in type 2 diabetes. During the 82nd Scientific Sessions, members of the consensus report writing group, including Philip Schauer, MD, discussed the rationale behind the report’s recommendations.


  • Researchers are examining the relationship between low-calorie sweeteners, obesity, and metabolic health

    Little is known about the impact of low-calorie sweeteners on taste preferences, insulin secretion, adipogenesis, the gut microbiome, glucose absorption, and the risk of cardiometabolic disease, according to Michelle Pang, BSc. One reason for that is that they are structured differently but are often studied together, resulting in conflicting findings.


  • Panelists share strategies for incorporating weight loss into type 2 diabetes care

    Most type 2 diabetes complications are related to excess adiposity, Dina Griauzde, MD, MSc, explained at the 82nd Scientific Sessions. Experts explored the benefits of weight loss for patients with type 2 diabetes, as well as medical management and surgical options for achieving weight loss.


  • Kelly West Award Lecture outlines precision prevention for type 1 diabetes

    IJust as precision medicine matches treatment approaches with individuals most likely to respond, precision prevention matches prevention measures to those most likely to show benefit. Jill M. Norris, MPH, PhD, discussed the interplay between genetic and dietary factors in reducing the risk of type 1 diabetes during this year’s Kelly West Award for Outstanding Achievement…


  • New incretins poised to improve clinical care and cardiometabolic outcomes

    Carol H. Wysham, MD, says there is serious therapeutic inertia at play as patients often remain in poor glycemic control for more than seven years before intensification of treatment. Yet repeated studies show that up-titrating GLP-1 receptor agonist dosing improves glycemic outcomes as well as loss and maintenance of weight.


  • Panel: Helping young adults manage diabetes requires better education

    An expert panel including Paul McGuigan, RN, CDCES, stressed that creating a continuum of care and support starting in high school, including promoting health insurance literacy, is key to setting up young people with type 2 diabetes to successfully manage their disease as they transition to adulthood.


  • Research begins to explain why time of day affects efficacy of interventions such as exercise in type 2 diabetes

    Afternoon training improves glucose sensitivity, increases fat loss, and increases work performance while reducing nocturnal blood glucose levels, said Juleen R. Zierath, PhD, one of the panelists discussing the molecular mechanisms known to affect the circadian rhythms of liver function.


  • Behavioral therapy and self-monitoring are critical to weight loss, panel says

    Four weight loss researchers discussed the value of behavioral therapy, intensive lifestyle interventions, and pharmacotherapy during a Scientific Sessions symposium on Sunday, June 5. “There’s quite a bit of evidence showing that individuals who self-monitor over time generally are the best in terms of maintenance of behaviors and weight,” said Hollie Raynor, PhD, RD, LDN.


  • Educating hospital staff about diabetes care improves patient outcomes

    A panel of clinical leaders discussed the importance of educating hospital staff about diabetes management and care during a Scientific Sessions symposium on Monday, June 6. “It really does affect the patient experience when we don’t do an excellent job managing their glycemia, and that’s the point of education,” said Leigh B. Bak, MSN, APRN,…


  • Researchers are gaining better understanding of increased risk of cognitive decline, dementia in type 2 diabetes

    Three neurological researchers—Auriel Willette, PhD, Vera Novak, MD, PhD, and Valory Pavlik, PhD (left to right)—will discuss the links between diabetes and cognitive decline and explore possible interventions during a Scientific Sessions symposium on Tuesday, June, 7.